Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Milestone

The proposal must be received at the company's principal executive offices not less than 120 calendar days before the date of the company's proxy statement released to shareholders in connection with the previous year's annual meeting

i.e. Not less than 120 days before December 8 (2009) 2010.
.
.
.
Be well
Share
New Message
Please login to post a reply